PPARGC1A and Parkinson disease: Chemically restoring the activity of the endogenous PGC-1α-regulated circuit (i.e., reduced in Parkinson's neuropathology) back to normal may be a more advantageous strategy for early intervention in incipient PD than forced overexpression of exogenous PGC-1α.